Usefulness of MCDA and examples
In this post we summarize its usefulness, the advantages and disadvantages, and we present two examples.
10 steps and tips on how to do an MCDA
There are many guidelines that teach you how to do an MCDA. Based on the guidelines available, and on the learnings we have been accumulating, here are the 10 steps you need to follow.
Multi Criteria Decision Analysis (MCDA)
Multi Criteria Decision Analysis (MCDA) is a tool to support decision making in health care. It complements other tools. It does not replace them.
The more complex the decisions, the more useful it will be.
Why? Because it is structured. It is multidisciplinary. It is transparent. It is systematic. And it incorporates several criteria. Hold your thoughts: we will come back to that.
Healixia Conference: Deep Dive into BeNeLuxA
On May 23rd , we joined the learning event about the BeNeLuxA initiative. https://www.healixia.be/meetings-detail-pagina/611/healixia-conference-deep-dive-into-beneluxa More about the BeNeLuxA initiative: https://beneluxa.org/collaboration
Innovation for Health – 2023
On 6 April 2023 at WTC Rotterdam, Vivactis Market Access attended the 10th edition of the leading conference for key players in Health & Life Sciences, Innovation for Health! The theme for this edition was Digital Transformation in Healthcare! https://hyphenprojects.nl/i4h/programme-overview
Press release: Weber joins Vivactis Group
Vivactis Group, the leading European healthcare consultancy group, announces its acquisition of Weber, a Market Access Consultancy firm and specialist in Health Economics and Outcomes Research (HEOR). The acquisition strengthens the Vivactis HM3A Market Access branch by expanding the reach in Market Access throughout Europe, as well as adding complementary HEOR and research science expertise.
European Health Summit 2022
Vivactis Market Access attended the the European Health Summit on December 8th in Brussels, Belgium.
Reimbursement for a medical device in Belgium
A medical device company, active in the field of cardiovascular diseases, wanted to apply for national reimbursement in Belgium.
Market Access Consultancy for a biopharmaceutical company
An American biopharmaceutical company asked Vivactis Market Access for services related to market access consulting for its portfolio to contribute to its goals of serving the community as well as contribute to grow its business in the Benelux.
The reimbursement pathway for digital mobile health applications in Belgium
The health app regulatory framework for financing of medical apps was announced in January 2021. This framework consists of a so-called ‘validation pyramid’ with 3 levels. Apps at level 3 are eligible for government funding.
Health Technology Assessment and a new EU Regulation – Part II
How and when will it impact your business?
Engage – by Pharma.be
Vivactis Market Access attended the the Engage networking event on November 24th in Brussels, Belgium. The event was organised by Pharma.be
Value Based Healthcare – by beMedTech
Vivactis Market Access attended the the Value Based Healthcare event on November 22nd in Brussels, Belgium. The event was organised by beMedTech with as topic ‘Geïntegreerde zorg: TO .be OR NOT TO .be’.
MARK NUIJTEN, MD, PhD – SENIOR HEALTH ECONOMIST
Mark Nuijten is medical doctor, health economist, market access and pricing consultant, valuation economist, and healthcare policy journalist. Mark Nuijten has a varied career in the health academic and business environment. He is pursuing development of economic modelling and broadening its application in health care and finance. His reimbursement dossiers, incl. cost-effectiveness and BIA models, successfully […]
LINA TEMIMI – MARKET ACCESS CONSULTANT
Lina graduated with a Master’s degree in Pharmaceutical Sciences from the Université libre de Bruxelles (ULB) in Belgium. She completed her master thesis with a “magna cum laude” in the field of digital health. The subject of the thesis was “The Introduction of Innovative Digital Health Technologies in the Belgian Healthcare System – A comparison […]
CHRIS JULIAM
Barbara holds a PhD in Biomedical Sciences (Ghent University, Belgium) and received training in Conceptual Selling (Miller Heiman) and Digital Transformation (Vlerick Business School, Belgium). In 2020, Barbara was nominated as one of the 50 most inspiring women in Belgian Tech.She acquired Sales and Marketing, Business Development and Management skills in an international context within […]
Science for Health – by MEDVIA
Vivactis Market Access attended the Science for Health event on November 21st in Brussels, Belgium. The event was organised by MEDVIA with as topic ‘Advancing Gene Therapy’.
Health Technology Assessment and a new EU Regulation – Part I
What are Health Technology Assessments? What is their purpose? Why does the new regulation matter?